Category: Clinical Breakthroughs
-
Using Stem Cells to Predict Toxicity of Chemotherapy Drugs
A Northwestern Medicine study has established a new safety index for a common group of chemotherapy drugs, by using a stem cell model to screen such therapies for cardiotoxicity.
-
Comparing Implanted Devices for Advanced Heart Failure
A recent study, published in the New England Journal of Medicine, found a newer left ventricular assist device performed at least as well as existing devices on the market for patients with advanced heart failure.
-
Evaluating A Novel Chemo-free Combination Therapy for Lymphocytic Leukemia
A phase 1 clinical trial of venetoclax and rituximab combination therapy was shown to be an effective chemo-free treatment option for patients with difficult-to-treat chronic lymphocytic leukemia.
-
Evaluating a Therapy for Rare Midgut Tumors
In recent Northwestern Medicine clinical trials, an experimental drug improved survival rates for patients with advanced midgut neuroendocrine tumors compared to a standard therapy.
-
Updating Red Blood Cell Transfusion Guidelines
An article published in JAMA recommends new updates to the red blood cell transfusion guidelines by the American Association of Blood Banks.
-
Lurie Cancer Center to Lead Trial for Rare Cancer Patients
A novel national trial for people with no established alternative to treat their rare cancers is being co-led by Northwestern Medicine investigators, who helped conceive of and develop the project.
-
Jet Lag Impairs Performance of Major League Baseball Players
When Major League Baseball players travel in a way that misaligns their internal 24-hour clock with the natural environment and its cycle of sunlight, they suffer negative consequences, according to a recent study.
-
Clinical Trials Evaluate New Treatment for Anal Cancer
The addition of the drug cetuximab to standard chemoradiation reduced the incidence of relapse for patients with anal cancer, but was associated with significant adverse effects, according to recent Northwestern Medicine clinical trials.
-
Children Born With Heart Defects at Increased Risk for Epilepsy
Children with congenital heart disease have a higher risk of epilepsy through adulthood, according to a recent Northwestern Medicine study.
-
Clinical Trial Assesses Non-Hodgkin Lymphoma Drug
A recent clinical trial assessed the efficacy and safety of the drug ibrutinib in patients with Waldenstrom’s macroglobulineaemia, a type of non-Hodgkin lymphoma, who were not responding to other treatments.
